| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $1.6M | — |
| SG&A Expense | $8K | +189.5% |
| Operating Income | -$146K | +40.6% |
| Interest Expense | $526K | +0.3% |
| Net Income | -$652K | +14.3% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $764K | -14.1% |
| Current Assets | $765K | -14.1% |
| Total Assets | $765K | -14.1% |
| Current Liabilities | $3.5M | -35.9% |
| Total Liabilities | $14.0M | +3.9% |
| Stockholders' Equity | -$13.3M | -5.2% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$125K | +50.1% |